Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Rabie Vaccine Bait

Awarded

0000411638State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of State Health Services for the state of Texas has issued an award notice for a contract regarding Rabie Vaccine Bait. This procurement, identified by solicitation number 0000411638, was posted on August 6, 2026, and is designated for performance within the state of Texas. The contract is managed by the Texas SLED organization, with Courtney Meads serving as the primary point of contact. Further details regarding the award can be accessed through the Texas SmartBuy portal.

General Info

Texas Department of State Health Services contract for Rabies Vaccine Bait in Texas.

Agency

Texas → Department of State Health Services

Contract Value

$696,213

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

TX, USA

Set-Aside

NONE

Awardee

BOEHRINGER INGELHEIM PHARMACEUTICALS INC

Award Issued Date

08/06/2026, 12:00:00 AM UTC

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedAug 6

Award Notice

AwardedAug 6

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyTexas → Department of State Health Services

Contacts1 person available

OfficeTX, USA

Organization / Agency

Texas → Department of State Health Services

Office AddressTX, USA

Contacts

contact@example.gov

Full Description

Show more

Rabie Vaccine Bait

Similar Contracts

Same NAICS industry code

Injectable Influenza Vaccine 2027

Solicitation # SPE2DP26R0003

Solicitation SPE2DP26R0003 is a request for Injectable Influenza Vaccine 2027 issued by the Department of Defense through DLA Troop Support, based in Philadelphia, Pennsylvania. This procurement falls under NAICS code 325414. The solicitation was posted on November 4, 2026, with a response deadline of December 3, 2026, at 8:00 PM. Primary contact for this effort is Rosbert Jones, with Melissa Rios Thomas serving as the secondary point of contact. Proposals must be submitted electronically via the DIBBS system in accordance with FAR 15.208(a). Submissions are subject to strict technical requirements, including a maximum file size of 10 MB per document and a 60-character limit for file names. File names must not contain spaces and may only use hyphens or underscores as special characters. Acceptable file formats include standard document, image, and spreadsheet extensions such as .pdf, .docx, and .xlsx.

DLA Troop Support

POSTED

about 12 hours ago

DEADLINE

Supply of Blood Grouping Serum, Anti-A, MonoclonalThis subcontract involves the supply of monoclonal antibody serum to prime contractors supporting DLA Troop Support medical supply contracts. Specifically, the provider is responsible for delivering 2,000 packages of Blood Grouping Serum, Anti-A, Monoclonal (NSN 6550-01-317-0288) in 10 ML vials. The contract is managed under the Department of Defense through the Medical Supply Chain MD Surg FSF. All materials must be packed and marked in accordance with Medical Marking Standard No. 1, MIL-STD-2073-1E, and Special Packaging Instructions MPACG00001. Additionally, the provider must ensure that all hazard labels are fully compliant with 29 CFR 1910.1200. The place of performance for this requirement is designated as APO 09227-0000.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

iPSC Culture and Differentiation

Solicitation # 75N98027Q00053

The National Institutes of Health, specifically the National Institute of Environmental Health Sciences, intends to award a firm-fixed-price purchase order to Creative Biolabs Inc. for iPSC culture and differentiation services. The scope of work involves culturing, differentiating, and expanding cell populations to over 20 million cells, followed by collection and verification. This effort supports a long-term study to sequence and analyze the complex 4q35 locus on Chromosome 4 using Nanopore Sequencing technology. The government is pursuing a sole-source acquisition because Creative Biolabs is identified as the only provider capable of following the specific required protocols and managing the necessary volume of cell lines within a three-month differentiation window. While the intent is to award to a single source, interested parties may submit capability statements to the designated point of contact by November 13, 2026, to demonstrate their ability to meet the technical and operational requirements.

National Institutes Of Health Olao

POSTED

DEADLINE

Scalable Biologic Manufacturing and FormulationThis subcontract focuses on the development of CMC strategies and scalable production processes for biologic therapies supporting prime contractors on NIH/NINDS projects. The scope of work involves utilizing bioreactors and cleanroom facilities to establish manufacturing processes and formulation strategies, ensuring that all quality attributes are validated in accordance with GMP and regulatory standards for clinical application. The successful provider will be responsible for delivering comprehensive scalable manufacturing documentation, formulated drug products, and detailed quality specifications. This effort is managed under the National Institutes of Health within the Department of Health and Human Services, falling under NAICS code 325414 for biologic product manufacturing.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

81627Y0875-Purchase of Raboravel V-RG Vaccines

Solicitation # 81627Y0875

The New York City Department of Health and Mental Hygiene (DOHMH) is seeking to establish a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the procurement of RABORAL V-RG coated sachet baits. This licensed oral rabies vaccine is used in the city's baiting program to immunize raccoons and reduce the transmission of rabies to other animals and humans. DOHMH has identified Boehringer Ingelheim as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Under the terms of the agreement, the vendor will provide up to 75,600 individual baits per contract year, sold in quantities of 300. Deliveries must be packed with cold packs and shipped to the NYC Public Health Laboratory at 455 First Avenue, New York, NY 10016, with each shipment accompanied by an invoice. Purchase quantities and delivery schedules will be determined by operational needs, including annual fall baiting campaigns, targeted spring baiting, or emergency responses to rabies outbreaks. Interested firms may submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

Department Of Health And Mental Hygiene

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.

Mrpbs Minneapolis Mn

POSTED

DEADLINE

Vaccination Campaigns - Procurement of Animal Vaccines.

Solicitation # GC3G2C

The Council for Development and Reconstruction is seeking solicitations for the procurement of animal vaccines to support vaccination campaigns within Lebanon. This federal initiative is managed by the Funding Division, with Oussama Kobeissi serving as the primary point of contact for interested parties. The solicitation, identified by number GC3G2C, was posted on October 22, 2026, and requires responses to be submitted by the deadline of December 3, 2026. All performance of the contract will take place in Lebanon.

Council for Development and Reconstruction

POSTED

DEADLINE

JAPANESE ENCEPHALIT

Solicitation # SPE2DP-26-R-0001

Solicitation SPE2DP-26-R-0001 is a sole source, firm-fixed price, indefinite delivery, indefinite quantity contract issued by the Defense Logistics Agency for the procurement of Japanese Encephalitis Virus Vaccine (NSN 6505-01-607-7018). The resulting contract will have an eighteen month base term, with a requirement that complete order quantities be delivered FOB Destination to DLA Distribution Susquehanna within 120 days after the date of order. The vaccine must be a purified, inactivated, single-dose prefilled syringe that is FDA approved and serialized in accordance with the Drug Supply Chain Security Act. Strict adherence to Medical Procurement Item Description Number 5 and Medical Marking Standard No. 1D is required, specifically regarding cold chain storage between 2 and 8 degrees Celsius and detailed military packaging and marking standards. Proposals must be submitted electronically via the DLA Internet Bid Board System by November 6, 2026. Award will be based on the most advantageous offer, evaluating FDA approval, supply availability assurance, agreement to all terms without exception, and price. Invoicing and receiving reports must be processed through the Wide Area Workflow system.

Defense Logistics Agency

POSTED

DEADLINE

VAC to Finished Vaccine ConversionThis subcontract involves the conversion of Government-owned Vaccine Antigen Concentrate into final-use Foot and Mouth Disease vaccine doses for prime contractors supporting USDA APHIS projects. The scope of work includes formulating the concentrate into a usable vaccine, performing filling and packaging within cleanroom facilities, and conducting essential final potency and efficacy testing. The project is managed under the Department of Agriculture and will be performed in Ames, Iowa. To be eligible, the contractor must hold a USDA Veterinary Biological Product License. The solicitation was posted on October 1, 2026, with a response deadline of November 10, 2026, falling under NAICS code 325414.

Mrpbs Minneapolis Mn

POSTED

about 1 month ago

DEADLINE

FMD Vaccine Antigen Concentrate (VAC) ProductionThis subcontract for the Department of Agriculture involves the production of Foot and Mouth Disease Vaccine Antigen Concentrates for prime contractors on USDA APHIS projects. The scope of work includes the purification and concentration of VAC serials, which are produced by engineering Master Seed Viruses or utilizing field strains in accordance with 9 CFR Parts 113 and 114. To qualify, the provider must possess a USDA Veterinary Biological Product License and provide propagation cell line data approved by the Center for Veterinary Biologics. The final deliverables are purified and concentrated FMD VAC serials, with performance taking place in Ames, Iowa. The response deadline for this opportunity is November 10, 2026.

Mrpbs Minneapolis Mn

POSTED

about 1 month ago

DEADLINE

Antithrombin III Procurement

Solicitation # CBP-CON-00260

The National Blood Authority is seeking tenders for the procurement of an Antithrombin III product under solicitation number CBP-CON-00260. While the agency currently maintains supply arrangements for Thrombotrol through the National Fractionation Agreement for Australia, this request for tender opens the process for the provision of these essential medical supplies. Interested parties must submit their responses by the deadline of November 20, 2026. All inquiries and submissions should be directed to the CBP Procurement Team via the provided contact email. Further detailed specifications and requirements are contained within the official request for tender documentation.

National Blood Authority

POSTED

about 1 month ago

DEADLINE

Proteomics and Protein Expression AnalysisThe Proteomics and Protein Expression Analysis subcontract supports National Institutes of Health projects focused on identifying biomarkers related to substance exposure and brain development. The selected provider will perform protein identification and quantification for prime contractors using a variety of high-sensitivity methods, including mass spectrometry, ELISA, Western blotting, and protein-protein interaction assays via LC-MS/MS. To ensure the integrity of the results, the performing laboratory must adhere to ISO/IEC 17025 quality standards. The primary deliverables for this engagement consist of detailed quantitative biomarker reports and comprehensive protein expression profiles. This effort falls under NAICS code 325414 and is managed through the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

in over 2 years

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS